Evidence of the role of tick subolesin in gene expression by de la Fuente, José et al.
BioMed  Central
Page 1 of 16
(page number not for citation purposes)
BMC Genomics
Open Access Research article
Evidence of the role of tick subolesin in gene expression
José de la Fuente*1,2, Christine Maritz-Olivier3, Victoria Naranjo2, 
Patricia Ayoubi4, Ard M Nijhof5, Consuelo Almazán6, Mario Canales2, José M 
Pérez de la Lastra2, Ruth C Galindo2, Edmour F Blouin1, Christian Gortazar2, 
Frans Jongejan5,7 and Katherine M Kocan1
Address: 1Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, USA, 
2Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Ronda de Toledo s/n, 13071 Ciudad Real, Spain, 3Department of 
Biochemistry, Faculty of Natural and Agricultural Sciences, Agriculture Building, Lunnon Road, University of Pretoria, Pretoria, 0002, South Africa, 
4Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078, USA, 5Utrecht Centre for Tick-borne 
Diseases (UCTD), Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL, 
Utrecht, The Netherlands, 6Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Tamaulipas, Km. 5 carretera Victoria-Mante, 
CP 87000 Cd. Victoria, Tamaulipas, Mexico and 7Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, 
Private Bag X04, 0110, Onderstepoort, South Africa
Email: José de la Fuente* - jose.de_la_fuente@okstate.edu; Christine Maritz-Olivier - christine.maritz@up.ac.za; 
Victoria Naranjo - MVictoria.Naranjo@uclm.es; Patricia Ayoubi - ayoubi@biochem.okstate.edu; Ard M Nijhof - A.M.Nijhof@uu.nl; 
Consuelo Almazán - consuelo_almazan@yahoo.com.mx; Mario Canales - mario.canales@UCLM.es; José M Pérez de la 
Lastra - josemanuel.plastra@uclm.es; Ruth C Galindo - ruthcecilia.galindo@uclm.es; Edmour F Blouin - edmour.blouin@okstate.edu; 
Christian Gortazar - christian.gortazar@uclm.es; Frans Jongejan - F.Jongejan@uu.nl; Katherine M Kocan - katherine.kocan@okstate.edu
* Corresponding author    
Abstract
Background: Subolesin is an evolutionary conserved protein that was discovered recently in
Ixodes scapularis as a tick protective antigen and has a role in tick blood digestion, reproduction and
development. In other organisms, subolesin orthologs may be involved in the control of
developmental processes. Because of the profound effect of subolesin knockdown in ticks and
other organisms, we hypothesized that subolesin plays a role in gene expression, and therefore
affects multiple cellular processes. The objective of this study was to provide evidence for the role
of subolesin in gene expression.
Results: Two subolesin-interacting proteins were identified and characterized by yeast two-hybrid
screen, co-affinity purification and RNA interference (RNAi). The effect of subolesin knockdown
on the tick gene expression pattern was characterized by microarray analysis and demonstrated
that subolesin RNAi affects the expression of genes involved in multiple cellular pathways. The
analysis of subolesin and interacting protein sequences identified regulatory motifs and predicted
the presence of conserved protein kinase C (PKC) phosphorylation sites.
Conclusion: Collectively, these results provide evidence that subolesin plays a role in gene
expression in ticks.
Published: 2 August 2008
BMC Genomics 2008, 9:372 doi:10.1186/1471-2164-9-372
Received: 18 February 2008
Accepted: 2 August 2008
This article is available from: http://www.biomedcentral.com/1471-2164/9/372
© 2008 de la Fuente et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
Page 2 of 16
(page number not for citation purposes)
Background
Ticks are obligate hematophagous ectoparasites of wild
and domestic animals and humans, and are important
vectors of diseases to humans and animals worldwide [1].
Ticks are classified in the subclass Acari, order Parasiti-
formes, suborder Ixodida and are distributed worldwide
from Arctic to tropical regions [2]. Despite efforts to con-
trol tick infestations, these ectoparasites remain a serious
threat for human and animal health [3,4]. Recently, both
vaccine studies using key tick antigens as well as character-
ization of tick gene function by RNA interference (RNAi)
have provided new information on genes that impact tick
life cycle and the tick-pathogen interface [3-6].
One of these genes, subolesin (also called 4D8), was dis-
covered recently in Ixodes scapularis and was shown by
both RNAi and immunization with recombinant proteins
to protect against tick infestations, resulting in reduced
tick survival, feeding and reproduction [7-11]. The silenc-
ing of subolesin expression by RNAi in ticks resulted in
degeneration of gut, salivary gland, reproductive and
embryonic tissues as well as causing sterility in males [10-
13]. In addition, targeting subolesin by RNAi or vaccina-
tion decreased the ability of ticks to become infected with
Anaplasma marginale or A. phagocytophilum [14,15].
Evidence of the conservation of subolesin throughout
evolution was provided by the high homology of amino
acid sequences in higher eukaryotes, which suggests an
essential conserved biological function for this protein
[10]. For example, the expression of subolesin orthologs
has been detected in a variety of adult and immature tis-
sues of several tick species [8,10,12], Drosophila mela-
nogaster  [16,17] and Caenorhabditis elegans [18]. These
studies have suggested that subolesin orthologs may be
involved in the control of developmental processes in
these organisms [8,10,12,16-18]. However, despite the
important role that subolesin plays in tick reproduction,
development and pathogen infection, the biological func-
tion of subolesin and its orthologs has not been reported.
Because of the profound effect of subolesin knockdown in
ticks and other organisms we hypothesized that subolesin
may play a role in gene expression, thus affecting multiple
cellular processes. Herein, gene expression is understood
as the process by which a gene gets turned on in a cell to
make RNA and proteins and therefore may be affected at
the transcriptional and/or translational levels. The objec-
tive of this study was to provide evidence for the role of
subolesin in gene expression through a combination of
methodological approaches that included characteriza-
tion of subolesin-interacting proteins, the effect of gene
knockdown on tick gene expression pattern and the pre-
diction of subolesin post-translational modifications.
Although the biological function of subolesin is unkown,
the results provided evidence that this protein plays a role
in gene expression in ticks and most likely other organ-
isms.
Results
Identification of subolesin interaction proteins by yeast 
two-hybrid screen and co-affinity purification
For discovery of subolesin-interacting proteins, subolesin
was used as a bait to search for preys in Rhipicephalus
(Boophilus) microplus using the yeast two-hybrid system.
Two sequences, GI and GII, were identified that encoded
for candidate subolesin-interacting proteins. These
sequences were represented in 50% and 10% of the posi-
tive clones, respectively. BLAST analysis of the GI
sequences did not result in identity to known sequences,
except for the EST910636 from a R. microplus cDNA
library. However, a transduction/transcription domain
was found within the GI open reading frame (ORF) (Fig.
1). The GII sequence was 99% identical (Expect = 4e-102)
to Amblyomma sp. elongation factor-1 alpha (EF-1a; [Gen-
bank:AAK12647]) and to other proteins containing
EF1_alpha_II and EF1_alpha_III domains (Fig. 2). Both
GI and GII sequences contained multiple N-myristoyla-
tion and casein kinase II (CK2) and protein kinase C
(PKC) phosphorylation sites (Figs. 1 and 2).
The proteins encoded by GI and GII were expressed in
Escherichia coli fused to a 6xHis tag with molecular weights
of 10 and 22 kDa, respectively and the interaction of these
proteins with subolesin was confirmed by co-affinity puri-
fication on Ni-NTA columns (Fig. 3). In the absence of
either GI or GII recombinant proteins or in the presence
of an unrelated His-tagged protein, co-purification of sub-
olesin did not occur, confirming the specificity of the
interaction between subolesin and GI or GII (Fig. 3 and
data not shown).
Characterization of the effect of GI and GII knockdown on 
tick survival, feeding, oviposition, hatching and egg 
development
RNAi was used to study the effect of the knockdown of
subolesin-interacting protein-coding genes, GI and GII,
on female tick survival, feeding, oviposition, hatching and
egg development. Subolesin, GI or GII dsRNAs or injec-
tion buffer (saline control) were injected into either unfed
or replete R. microplus female ticks. The injection of GI
dsRNA did not affect tick survival, feeding and oviposi-
tion, a fact that correlated with the absence of GI knock-
down in ticks (Table 1). Although GI expression was
reduced in tick eggs, it did not affect hatching (Table 2).
Gene knockdown was demonstrated for GII and sub-
olesin in both ticks and eggs (Tables 1 and 2). GII knock-
down produced a phenotype similar to that obtained with
the silencing of subolesin expression. The injection of GII
dsRNA in unfed ticks resulted in reduced tick survival,BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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feeding, oviposition and hatching when compared to con-
trol ticks (Table 1). When GII dsRNA was injected into
replete ticks, hatching and egg development were affected
(Table 2 and Fig. 4). Undifferentiated egg masses were
observed in eggs oviposited by replete ticks injected with
GII and subolesin dsRNA when compared to saline
injected controls (Fig. 4).
Characterization of the effect of subolesin knockdown on 
tick gene expression profile
The results of the subolesin-protein interactions and RNAi
experiments with GI and GII, encoding for subolesin-
interacting proteins, suggested that subolesin may be
involved in gene expression in ticks. Therefore, the subse-
quent experiments were directed towards analyzing the
effect of subolesin knockdown on the tick gene expression
profile.
In the first experiment, the kinetics of subolesin silencing
by RNAi was investigated in unfed I. scapularis female
ticks. The results showed that over 90% silencing of sub-
olesin transcription was obtained 6 days post injection
(dpi) and continued until at least 11 dpi (Fig. 5). Signifi-
cant differences (P = 0.02) in tick weight between sub-
olesin dsRNA (78 ± 33 mg) and saline injected controls
(142 ± 47 mg) were observed in ticks that completed feed-
ing on the host in the presence of males at 11 dpi.
In the second experiment, unfed I. scapularis female ticks
were injected with subolesin dsRNA or injection buffer
alone. Ticks were then placed on a sheep without males
and collected at 6 and 9 dpi, by which time subolesin
knockdown was regarded as significant based on the RNAi
kinetics experiment (Fig. 5). Subolesin knockdown was
corroborated by real-time RT-PCR as 81 ± 3% and 79 ± 5%
silencing at 6 and 9 dpi, respectively. A group of ticks col-
lected after 10 days of feeding with males was used to cor-
roborate the effect of subolesin knockdown on tick
weight, giving results similar to those obtained in the
RNAi kinetics experiment described above. The ticks col-
lected at 6 and 9 dpi were then dissected and used to
extract RNA for suppression-subtractive hybridization
(SSH) and microarray construction and analysis.
The SSH libraries constructed with the RNA of subolesin
dsRNA and saline injected ticks collected at 9 dpi were
used for random clone amplification and microarray con-
struction. This microarray was enriched for genes differen-
tially expressed after subolesin knockdown. The
microarray was hybridized with total RNA prepared from
subolesin dsRNA- and saline-injected ticks at 6 and 9 dpi
to evaluate how the expression pattern of candidate differ-
entially expressed genes varied at two different time
points after subolesin knockdown (Table 3). The results
revealed 34 unique (not redundant) genes that were down
or up-regulated by at least two-fold after subolesin knock-
down at 6 or 9 dpi (Fig. 6). Of these genes, 28 were down-
Analysis of GI sequence encoding for subolesin-interacting protein Figure 1
Analysis of GI sequence encoding for subolesin-interacting protein. GI nucleotide and deduced amino acid sequences 
are shown. The GI sequence contains a transduction/transcription domain (boxed letters) and multiple N-myristoylation (solid 
line) and CK2 (dotted line) and PKC (dashed line) phosphorylation sites.
GCCATGGAGGCCGGGATAGGAGCTGCGTCATCCGGAAGCTCTGCGCAGGAAACGACCTGG 
M  E  A  G  I  G  A  A  S  S  G  S  S  A  Q  E  T  T  W
AAAGCGCCATGGCCGCTCACTTCACGAATGCTCAAATCACGGAGATTCACAACGCTGCTA 
K  A  P  W  P  L  T  S  R  M  L  K  S  R  R  F  T  T  L  L
CTACCTGCGATCCAGAGGCCGGGCATGGCCACCACCATCACTGAAAGCGGTTCGCACGGT 
L  P  A  I  Q  R  P  G M  A  T  T  I  T  E  S  G  S  H  G 
GTCTTCTGCGTGCTGACAGTTCCTATAGCTCTCGGAGTCACACCGTGGAGGGGCTCGACA 
V  F  C  V  L  T  V  P  I  A  L  G  V  T  P  W  R  G  S  T 
GAGATTTGTCTTAATGAGCATAACTATTTAACACAACAAGAAAAATAAATACATGTCGCC 
E  I  C  L  N  E  H  N  Y  L  T  Q  Q  E  K  *   
GAAAAAAAAAAAAAAAAAAAAAAAABMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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regulated and 6 were up-regulated after subolesin RNAi.
Of the down-regulated genes, 4 were down-reglated at 6
dpi, 20 at 9 dpi and 4 at both 6 and 9 dpi (Fig. 6). Up-reg-
ulated genes were found at 9 dpi only (Fig. 6). In the
microarray analysis, subolesin expression was silenced by
approximately 35% at both 6 and 9 dpi. Although 62% of
the unique differentially expressed genes did not have
homology to available sequences or were identical to
genes with unknown function, the remaining sequences
indicated that various biological processes were affected
by subolesin knockdown. These included regulation of
protein and nucleic acid metabolism (54% of protein
ontology assignments), energy pathways (15%), immu-
nity (15%), cell communication and signal transduction
(8%) and transport (8%).
Three of the down-regulated genes after subolesin knock-
down, identical to I. scapularis putative secreted salivary
WC peptide [Genbank:AAY66498] and putative secreted
protein [Genbank:AAM93633] and Macrobrachium rosen-
bergii  copper/zinc superoxide dismutase (Cu-Zn SOD)
[Genbank:AAZ29240], were selected to corroborate the
results of the microarray analysis by real-time RT-PCR.
The results demonstrated that the expression of these
genes was silenced after subolesin RNAi by 98% and
100% (for [Genbank:AAM93633]), 41% and 59% (for
[Genbank:AAY66498]) and 93% and 74% (for [Gen-
bank:AAZ29240]) at 6 and 9 dpi, respectively. Ticks
injected with an unrelated 4A8 dsRNA control did not
show silencing of these genes after RNAi. The possibility
of subolesin RNAi off-target effects was analyzed and
complementary 7 bp regions were not found between all
possible 20–22 bp subolesin siRNAs and tick cDNA
Analysis of GII sequence encoding for subolesin-interacting protein Figure 2
Analysis of GII sequence encoding for subolesin-interacting protein. GII nucleotide and deduced amino acid 
sequences are shown. The GII sequence contains EF1_alpha_II and EF1_alpha_III domains (boxed letters) and multiple N-myr-
istoylation (solid line) and CK2 (dotted line) and PKC (dashed line) phosphorylation sites.
AGGCCCACGGACAAACCCCTCCGACTTCCGCTGCAGGACGTCTACAAGATT 
R  P  T  D  K  P  L  R  L  P  L  Q  D  V  Y  K  I
GGTGGCATTGGCACGGTGCCAGTCGGCCGTGTGGAGACCGGTGTCCTCAAG 
G  G  I  G  T  V  P  V  G  R  V  E  T  G  V  L  K 
CCCGGCATGGTCGTCACCTTTGCCCCTGCCAACCTGACCACTGAGGTCAAG 
P  G  M  V  V  T  F  A  P  A  N  L  T  T  E  V  K 
TCTGTGGAGATGCACCACGAGGCCCTCGCAGAGGCCGTGCCCGGCGACAAC 
S  V  E  M  H  H  E  A  L  A  E  A  V  P  G  D  N 
GTCGGCTTCAACGTCAAGAACGTCTCGGTGAAGGAGCTGCGCCGAGGATAT 
V  G  F  N  V  K  N  V  S  V  K  E  L  R  R  G  Y 
GTGTGTGGAGACTCGAAGGACACTCCACCGAAGTCCACGGAGGAGTTCACT 
V  C  G  D  S  K  D T  P  P  K  S  T  E  E  F  T
GCCCAGGTTATTGTGCTGAACCATCCCGGCCAGATTGCAAACGGCTACACG 
A  Q  V  I  V  L  N  H  P  G  Q  I  A  N  G  Y  T 
CCTGTGTTGGACTGCCACACAGCCCACATTGCCTGCAAGTTCAGGGAGATC 
P  V  L  D  C  H  T  A  H  I  A  C  K  F  R  E  I 
AAGGAAAAGTGTGACCGTCGTTCTGGCAAGAAGCTCGAGGACAACCCCAAG 
K  E  K  C  D  R  R  S  G  K  K  L  E  D  N  P  K 
TTCATCAAGTCTGGCGATGCTGCGATCATTGACCTGGTACCTTCCAAGCCC 
F  I  K  S  G  D  A  A  I  I  D  L  V  P  S  K  P 
ATGTGCGTCGAAACCTTCACCGACTTTCCTCCCCTTGGTCGCTTCGCTGTC 
M  C  V  E  T  F  T  D  F  P  P  L  G  R  F  A  V 
CGTGACATGAGGCAAACGGTCGCC 
R  D  M  R  Q  T  V  A
EF1_alpha_II
domain
EF1_alpha_III
domainBMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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sequences of differentially expressed genes identified in
the microarray analysis.
Prediction of subolesin conserved post-translational 
modifications
I. scapularis subolesin [Genbank:AAV67031] and human
ortholog C6orf166 [Genbank:NP_060534] proteins were
compared to predict conserved post-translational modifi-
cations. Three conserved PKC phosphorylation sites were
found (Fig. 7), which were also present in all known tick
subolesin protein sequences (data not shown).
Discussion
Subolesin, discovered and characterized in I. scapularis as
a tick protective antigen [7-9], is an evolutionary con-
served protein which is involved in modulation of tick
blood digestion, reproduction and development [10-13].
In other organisms, subolesin orthologs may be involved
in the control of developmental processes [16-18].
Although the function of subolesin is unknown, these
results suggest a conserved function for subolesin. Because
of the profound effect of subolesin knockdown in ticks
and other organisms [10-13,18], our hypothesis was that
subolesin may have a role in gene expression, thus affect-
ing multiple cellular processes. Therefore, the objective of
Co-affinity purification assays Figure 3
Co-affinity purification assays. The supernatant of GI- and GII-expressing E. coli cell lysates were loaded onto Ni-NTA col-
umns, washed, then loaded with purified recombinant subolesin and washed again before protein elution for SDS-PAGE and 
Western blot. The top panel shows subolesin bait detection after affinity purification on Ni-NTA columns in the presence (+) 
or absence (-) of His-tagged GI/GII protein extracts, demonstrating binding to His-tagged prey. The bottom panel shows detec-
tion of GI/GII His-prey after affinity purification on Ni-NTA columns.
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Table 1: R. microplus tick survival, weight, oviposition and hatching after RNAi in unfed female ticks.
Experimental 
group
Number of ticks Expression 
silencing (%)a
Tick weight 
(mg)b
Mortality (%)c Eggs per tick 
(mg)d
Hatching rate 
(%)
Saline control 76 --- 295 ± 85 21 111 ± 75 > 90
GI 60 -44 ± 29 266 ± 114 17 110 ± 72 > 90
GII 63 98 ± 0.4* 131 ± 161** 60*** 1 ± 4**** 0*****
Subolesin 66 91 ± 3* 73 ± 94** 80*** 0**** ND
aThe expression silencing of target genes was determined by real-time RT-PCR and average ± SD mRNA levels calculated and compared between 
dsRNA and saline-injected control ticks by Student's t-test with unequal variance (*P < 0.01). Amplification efficiencies were normalized against β-
actin.
bTicks which completed feeding and those removed after 30 days (15 days after saline or dsRNA injection) were weighed individually and average ± 
S.D. calculated and compared between dsRNA and saline-injected control ticks by Student's t-test with unequal variance (**P < 0.01).
cTick mortality was evaluated as the ratio of dead female ticks after day 30 (15 days after saline or dsRNA injection) to the total number of female 
ticks placed on the animal and was compared between dsRNA and saline-injected control ticks by χ2-test (***α < 0.001).
dThe egg mass oviposited by each tick was weighed individually and average ± S.D. calculated and compared between dsRNA and saline-injected 
control ticks by Student's t-test with unequal variance (****P < 0.01).
eThe hatching rate was determined 6 weeks after oviposition and compared with the saline-injected control ticks by Student's t-test with unequal 
variance (*****P < 0.01).
Abbreviations: ND, not determined because ticks did not laid eggs.BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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this study was to provide evidence of the role of subolesin
in gene expression. To test this hypothesis, three experi-
ments were conducted. In the first series of experiments,
subolesin-interacting proteins were identified and charac-
terized in R. microplus, suggesting the interaction of sub-
olesin with regulatory proteins. Therefore, in the second
series of experiments, the effect of subolesin knockdown
was analyzed in I. scapularis and showed the effect of sub-
olesin on gene expression affecting different biological
processes. Finally, post-translational modifications were
predicted for tick subolesin. All together, the results of
these experiments suggested a role for tick subolesin in
gene expression.
To identify proteins that interact with subolesin in yeast
two-hybrid experiments, we used a cDNA library obtained
from tick eggs because subolesin is expressed in tick
embryos and gene knockdown affects egg development
[8,12]. Two genes, GI and GII, were identified encoding
for proteins that interact with tick subolesin. These pro-
teins contained domains and post-translational modifica-
tion sites found in proteins with regulatory functions. The
transduction/transcription domain found in GI is present
in phosphorylated proteins involved in transcriptional
regulation and other cell functions related to gene expres-
sion [19,20]. The EF1_alpha_II and EF1_alpha_III
domains present in GII are found in proteins with differ-
ent functions such as protein biosynthesis, DNA binding,
transcriptional regulation, RNA processing, structural
constituent of cytoskeleton as well as ATP and GTP bind-
ing that are also involved in gene expression (see for
example proteins with accession numbers [Gen-
bank:EAY95388, Genbank:XP_657651, Gen-
bank:XP_404184, Genbank:XP_312333,
Genbank:XP_001651261]).
The results reported herein suggested that subolesin may
interact with regulatory proteins. In other organisms, sub-
olesin orthologs interact with proteins with gene expres-
sion regulatory activities. The human subolesin ortholog
interacts with LNXp80 [Genbank:AK056823], DIPA [Gen-
bank:NM_006848] and SPG21 [Genbank:NM_016630]
proteins. LNX is an E3 ubiquitin-protein ligase that medi-
ates ubiquitination and subsequent proteasomal degrada-
tion of Numb, implicated in the control of cell fate
decisions during development. DIPA interacts with the
viral phosphoprotein hepatitis delta antigen (HDAG) and
acts as a repressor of gene transcription [21]. SPG21 binds
to the hydrophobic C-terminal amino acids of CD4 which
are involved in repression of T cell activation [22]. In D.
melanogaster, the subolesin ortholog bhringi  (bhr;
CG8580) may act to regulate Twist activity through
recruitment of the chromatin remodeling Brahma com-
plex [17]. Therefore, subolesin may exert its effect on gene
expression through the interaction with GI, GII and possi-
bly other regulatory proteins. Interestingly, the GII knock-
down phenotype was similar to that obtained with
subolesin, suggesting that these proteins may functionally
interact in ticks.
The results of the microarray analysis of gene expression
profile in ticks after subolesin knockdown provided evi-
dence for the role for subolesin in gene expression. Sub-
olesin knockdown affected the expression of genes
involved in multiple cellular pathways. The nonspecific
effect of dsRNA injection on tick global gene expression
was not addressed in these studies. However, the injection
of an unrelated dsRNA did not affect the expression of
selected genes differentially expressed after subolesin
knockdown. Although we cannot rule out off-target effects
of subolesin RNAi in ticks, evidence suggested that this
was not a likely possibility to explain the effect of sub-
olesin knockdown on tick gene expression pattern. Firstly,
we did not find complementary sequences between sub-
olesin and identified differentially expressed genes that
could support off-target effects of subolesin RNAi. To
Table 2: Weight, oviposition and hatching of replete R. microplus female ticks after RNAi.
Experimental group Tick weight (mg)a Eggs per tick (mg)b Hatching rate (%)c Expression silencing (%)d
Saline control 318 (272–367) 173 (128–229) > 90 ---
GI 318 (260–369) 123 (31–175) > 90 55 ± 8**
GII 315 (267–349) 132 (95–182) 0.2* 84 ± 5**
Subolesin 318 (270–360) 142 (101–175) 0.4* 46 ± 8**
aReplete R. microplus ticks were collected and weighed individually before injection with dsRNA, all within 6 hours after dropping of the host. The 
average weight and variation (between parentheses) of each group are shown. No significant statistical differences were observed (P > 0.05).
bThe egg mass oviposited by each tick was weighed individually. The average egg mass and variation (between parentheses) was calculated and 
compared with the saline-injected control ticks by Student's t-test with unequal variance. No significant statistical differences were observed (P > 
0.05).
cThe hatching rate was determined 6 weeks post oviposition and compared with the saline-injected control ticks by Student's t-test with unequal 
variance (*P < 0.01).
dThe expression silencing of target genes was determined in eggs by real-time RT-PCR and average ± S.D. mRNA levels calculated and compared 
between dsRNA and saline-injected control ticks by Student's t-test with unequal variance (**P < 0.05). Amplification efficiencies were normalized 
against β-actin.BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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search for complementary sequences between subolesin
and identified differentially expressed genes, we used the
approach proposed by Birmingham et al. [23] who
showed that although maximum complementarity by
itself is an unsatisfactory predictor of off-target RNAi
effects, a highly significant association exists between off-
targeting and exact complementarity between the seed
region (bases 2–8) of siRNA and their off-targeted gene 3'
untranslated region (UTR). Secondly, the analysis of D.
melanogaster  subolesin ortholog RNAi off-target effects
demonstrated the presence of a single off-targeted gene
[24], suggesting that off-target effects of subolesin RNAi
may also be minimal in ticks.
A common characteristic of many regulatory protein
sequences is the presence of phosphorylation sites.
Although we did not demonstrate phosphorylation of tick
subolesin, there is evidence that the human ortholog pro-
Representative R. microplus eggs from replete female ticks injected with injection buffer alone (saline control) showing normal  development, or GII and subolesin dsRNA showing an undifferentiated egg mass Figure 4
Representative R. microplus eggs from replete female ticks injected with injection buffer alone (saline control) 
showing normal development, or GII and subolesin dsRNA showing an undifferentiated egg mass. Eggs were 
incubated at 27°C and 95% relative humidity. Photographs were taken 22 dpi of replete females and 19 days after oviposition. 
Bar = 0.1 mm.
GII
Control
SubolesinBMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
Page 8 of 16
(page number not for citation purposes)
tein undergoes phosphorylation at serine 21 (AS*PKRRR)
[25], a PKC phosphorylation site that is conserved in tick
sequences. Therefore, as with other regulatory proteins,
subolesin may be regulated by reversible phosphorylation
by PKC.
Conclusion
In summary, the results presented herein provide evi-
dence that support a role for subolesin in gene expression
in ticks and other organisms. The regulatory function of
subolesin in gene expression may be exerted through
interaction with other regulatory proteins at the transcrip-
tional level (Fig. 8). In fact, a recent publication by Goto
et al. [26] that appeared after submission of our work
renamed subolesin orthologs in insects and vertebrates as
Akirins and proposed that they constitute transcription
factors required for NF-kB-dependent gene expression in
Drosophila  and mice. Alternatively, subolesin may also
interact with proteins involved in translational control in
ticks (Fig. 8). The experimental approach used in this
study may be important for the annotation of tick
sequences that result from genome sequencing efforts
[27] and for the characterization of candidate tick protec-
tive antigens for the development of vaccines for the con-
trol of tick infestations and the transmission of tick-borne
pathogens [3].
Methods
Ticks
I. scapularis female ticks were obtained from the labora-
tory colony maintained at the Oklahoma State University
tick rearing facility. Off-host ticks were maintained in a 12
hr light: 12 hr dark photoperiod at 22–25°C and 95% rel-
ative humidity. R. microplus female ticks (Mozambique
strain) were reared in Holstein-Friesian cattle at the
Utrecht Centre for Tick-borne Diseases, Utrecht Univer-
sity. Animals were housed with the approval and supervi-
sion of the respective Institutional Animal Care and Use
Committees.
cDNA library construction
R. microplus eggs were used for RNA extraction and cDNA
library construction. cDNA synthesis and amplification
was performed using the Super SMART System™ principle
(Clontech Laboratories, Mountain View, CA, USA) with
adapted anchor primers containing unique SfiI restriction
sites for directional cloning (SMART IV: 5'-AAGCAGTGG-
TATCAACGCAGAGTGGCCATGGAGGCCGGG-3'and
Kinetics of subolesin RNAi Figure 5
Kinetics of subolesin RNAi. Ticks were injected with subolesin dsRNA (RNAi group) or injection buffer alone (control 
group). Three ticks from each group were collected at 1, 3, 6, 9 and 11 days post injection to determine mean ± SD subolesin 
mRNA ratio by real-time RT-PCR.
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Table 3: I. scapularis differentially expressed genes after subolesin knockdown.
Clone IDa Accession number, name and spe-
ciesb
Fold change (6 dpi)c SD (6 dpi)d Fold change (9 dpi)c SD (9 dpi)d
LibPlateC1_wellB12 [Genbank:AAT92189] KUN-6 (Ixodes 
pacificus)
-1.1196 0.2519 -2.2057 0.3109
LibPlateC1_wellB6 [Genbank:AAZ29240] copper/zinc 
superoxide dismutase (Macrobrachium 
rosenbergii)
-2.7645 0.5455 -2.5136 0.2930
LibPlateC1_wellD9 [Genbank:AAY66901] histone 2B (Ixodes 
scapularis)
-1.5922 1.5332 -2.5298 0.9579
LibPlateC1_wellE6 [Genbank:AAY66498] putative secreted 
salivary WC peptide (Ixodes scapularis)
1.2320 1.4160 -5.2598 1.3686
LibPlateC1_wellF10 [Genbank:AAY66817] anticoagulant Salp9-
like (Ixodes scapularis)
-2.0332 0.2959 -1.2037 0.1124
LibPlateC1_wellG12 [Genbank:AAZ29240] copper/zinc 
superoxide dismutase (Macrobrachium 
rosenbergii)
-1.6426 0.2527 -2.2118 0.4974
LibPlateC1_wellH10 No homology found -1.8346 0.7216 -2.0350 1.0821
LibPlateC1_wellH4 No homology found -1.6161 0.4640 -2.0602 0.5671
LibPlateC2_wellB11 [Genbank:AAY66498] putative secreted 
salivary WC peptide (Ixodes scapularis)
-1.8612 0.1952 -2.1981 0.1664
LibPlateC2_wellB12 No homology found -1.1313 0.1588 -2.1133 0.2023
LibPlateC2_wellD5 No homology found -1.6882 0.0965 -2.2689 0.2158
LibPlateC2_wellE3 [Genbank:AAY66498] putative secreted 
salivary WC peptide (Ixodes scapularis)
-1.0794 0.2033 -2.2673 0.2302
LibPlateC2_wellG1 [Genbank:AAM93633|AF483711_1] 
putative secreted protein (Ixodes scapularis)
-1.4409 0.2000 -3.5351 0.3250
LibPlateC3_wellB10 [Genbank:AAH67494] HIST1H3I protein 
(Homo sapiens)
-2.0111 0.2174 -2.3299 0.4323
LibPlateC3_wellB8 No homology found -2.0438 1.5307 -1.3772 0.5537
LibPlateC3_wellC7 [Genbank:AAZ29240] copper/zinc 
superoxide dismutase (Macrobrachium 
rosenbergii)
-4.1699 0.1770 -3.1053 0.0638
LibPlateC3_wellD7 [Genbank:AAZ29240] copper/zinc 
superoxide dismutase (Macrobrachium 
rosenbergii)
-2.5487 0.1977 -2.1210 0.4374
LibPlateC3_wellE2 [Genbank:XP_624446.2] Predicted similar 
to ruby CG11427-PA isoform 2 (Apis 
mellifera)
-2.4606 1.6665 -1.0115 0.3122
LibPlateC3_wellE9 [Genbank:AAZ29240] copper/zinc 
superoxide dismutase (Macrobrachium 
rosenbergii)
-3.4248 0.3717 -2.0792 0.2988
LibPlateC3_wellF10 [Genbank:AAM93633|AF483711_1] 
putative secreted protein (Ixodes scapularis)
-1.3583 0.2449 -3.9731 0.1679
LibPlateC3_wellF11 [Genbank:AAM93633|AF483711_1] 
putative secreted protein (Ixodes scapularis)
-1.0215 0.1441 -2.9246 0.1172
LibPlateC3_wellG5 [Genbank:AAM93633|AF483711_1] 
putative secreted protein (Ixodes scapularis)
-1.1451 0.2311 -3.7711 0.1890
LibPlateC4_wellB1 No homology found -1.7450 0.6400 -2.2268 0.3409
LibPlateC4_wellB10 [Genbank:AAQ01562] von Willebrand 
factor (Ixodes ricinus)
1.1202 0.3737 -3.9449 0.2800
LibPlateC4_wellB5 [Genbank:ABD83654] 
hemelipoglycoprotein precursor 
(Dermacentor variabilis)
-1.9958 0.5689 -3.5813 0.6757
LibPlateC4_wellB7 [Genbank:AAP84098] ML domain-
containing protein (Ixodes ricinus)
-1.5703 0.3164 -4.5599 0.4105
LibPlateC4_wellB8 No homology found -2.6551 0.3564 -3.5944 0.3325
LibPlateC4_wellC1 [Genbank:AAY66502] secreted salivary 
gland protein (Ixodes scapularis)
1.0009 0.2427 -2.2922 0.3518
LibPlateC4_wellC2 No homology found -1.0286 0.0610 -2.0853 0.1338
LibPlateC4_wellC6 No homology found -1.1217 0.1682 -2.7104 0.1235
LibPlateC4_wellD3 No homology found 1.6859 0.2075 2.6468 0.1954BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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CDS III: 5'-ATTCTAGAGGCCTCCATGGCCGA-
CATG(T)30VN-3'). Amplified cDNA was polished using
the protocol described by the SMART PCR cDNA synthesis
manual (Clontech Laboratories), purified using the DNA
Extract II Kit (Macherey-Nagel, Düren, Germany) and sub-
jected to directional cloning in pACT2 plasmid via the SfiI
sites. Repetitive electroporation of E. coli JM109 cells was
performed to obtain a library with a titer exceeding 3 × 107
cfu/ml.
Yeast two-hybrid screen
The yeast two-hybrid screen was performed as dictated in
the MATCHMAKER Two-Hybrid user manual (Clontech
Laboratories). Full-length subolesin cDNA from R. micro-
plus was inserted in yeast expression vector pAS2_1 at NdeI
and PstI sites. Yeast strain AH109 was co-transformed with
plasmid pAS2_1_subolesin (bait) and pACT2 R. microplus
egg cDNA library (prey) in sequential transformation pro-
cedure. The co-transformants were selected after incuba-
tion at 30°C for 5 days on synthetic defined (SD) minimal
medium lacking tryptophan and leucine. All colonies
were pooled from the plates and replated on SD minimal
medium lacking tryptophan, leucine, histidine and ade-
nine. Positive clones were analyzed for β-galactosidase
activity by colony-filter assays. Prey plasmids of positive
clones were rescued using E. coli KC8 and subjected to
DNA sequencing.
Confirmation of protein-protein interaction by co-affinity 
purification
The GI and GII cDNA fragments, encoding for putative
prey proteins interacting with the subolesin bait, were
amplified by PCR using oligonucleotide primers QEGI5:
5'-GGCCATGGAGGCCGGGATAGGA and QEGI3: 5'-
GGAGATCTATGCTCATTAAGACAAATCTC, and QEGII5:
5'-GGCCATGGCCTCAACCAGGCCCACGGACAAAC-
CCCTC and QEGII3: 5'-GGAGATCTGGCGACCGTTT-
GCCTCATGTC, respectively and the Access RT-PCR
system (Promega, Madison, WI, USA). The PCR primers
introduced NcoI and BglII restriction sites for cloning into
the expression vector pQE-60 fused to a 6xHis tag (Qiagen
Inc., Valencia, CA, USA). The full-length cDNA of I. scapu-
laris subolesin was inserted into the expression plasmid
pFLAG-CTC (Sigma, St. Louis, MO, USA) as described pre-
viously [8]. Recombinant subolesin, GI and GII proteins
were expressed in E. coli JM109 as described previously
[8]. For co-affinity purification of subolesin-interacting
proteins, the Ni-NTA spin columns (Qiagen) were used
following manufacturer's protocol. The supernatant of GI
and GII cell lysates were loaded onto the columns. The
columns were washed three times with washing buffer
(Qiagen) before loading the purified subolesin. The col-
umns were incubated at 4°C for 4 hours to allow protein-
protein interaction and then washed again. The proteins
were eluted with elution buffer (Qiagen) and the eluted
proteins were subjected to 12% sodium dodecyl sulfate-
LibPlateC4_wellD4 [Genbank:XP_974124] PREDICTED: 
similar to CG2972-PA (Tribolium 
castaneum)
-2.1335 0.2315 -2.6578 0.3642
LibPlateC4_wellF6 [Genbank:BAE53722] aspartic protease 
(Haemaphysalis longicornis)
-1.4881 0.2385 -4.8576 0.3690
LibPlateC4_wellG3 [Genbank:AAY66629] putative secreted 
salivary protein (Ixodes scapularis)
1.0601 0.1625 2.0049 0.1481
LibPlateC4_wellG4 [Genbank:XP_794044] Predicted similar to 
Endoplasmic reticulum-golgi intermediate
-2.2835 0.2324 -1.7916 0.5510
LibPlateC4_wellH4 [Genbank:AAY66660] putative salivary 
secreted protein (Ixodes scapularis)
-1.5502 0.2177 -5.1239 0.2056
LibPlateC4_wellH6 [Genbank:AAY66982] cyclophilin A (Ixodes 
scapularis)
-1.0545 0.0098 2.0388 0.2239
LibPlateR1_wellG3 No homology found 1.2792 0.2664 2.2118 0.1902
LibPlateR1_wellH7 [Genbank:AAY66764] putative secreted 
salivary protein (Ixodes scapularis)
1.2470 0.0447 -2.0598 0.0708
LibPlateR2_wellB2 [Genbank:AAY66713] putative secreted 
salivary protein (Ixodes scapularis)
1.4186 0.2490 2.2141 0.2145
LibPlateR2_wellF10 [Genbank:AAK97818|AF209915_1] 16 kDa 
salivary gland protein A (Ixodes scapularis)
-1.8100 0.4667 -2.4275 0.3690
LibPlateR2_wellG7 [Genbank:AAY66713] putative secreted 
salivary protein (Ixodes scapularis)
1.4101 0.1056 2.1495 0.1347
LibPlateR3_wellA7 No homology found -1.0338 0.1570 2.0213 0.1464
LibPlateR4_wellA3 No homology found -1.0990 1.1277 -3.4438 1.6338
aClone ID identifies the clone based on SSH Library Plate_well.
bName: This output only contains descriptions of the top blast hit (most significant alignment based on E value).
cFold change is of the global normalized ratio (log2(635/532)) of background-corrected means averaged between replicates (determined from valid 
spots only). Only genes down-regulated (negative values) and up-regulated (positive values) after subolesin knockdown by at least two fold at 6 or 
9 dpi were considered.
dSD is the standard deviation determined from the normalized average log2 ratio (determined from valid spots only).
Table 3: I. scapularis differentially expressed genes after subolesin knockdown. (Continued)BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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Effect of subolesin knockdown on tick gene expression pattern Figure 6
Effect of subolesin knockdown on tick gene expression pattern. The expression fold change was determined by micro-
array hybridization at 6 and 9 days post injection (dpi). Clone ID (SSH library plate and well) are shown and correspond to 
entries in Table 3. The graph was constructed with the HCE software http://www.cs.umd.edu/hcil/hce/hce3.html.
9             6
dpiBMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
Page 12 of 16
(page number not for citation purposes)
polyacrylamide electrophoresis (SDS-PAGE) and immu-
noblotted with anti-subolesin antibodies [8]. Controls
included affinity purification of GI and GII in the absence
of subolesin and loading subolesin onto Ni-NTA columns
in the absence of His-tagged GI and GII proteins and in
the presence of an unrelated His-tagged protein. GI and
GII proteins were detected by Western blot using the His-
Detector Western Blot Kit HRP (KPL, Gaithersburg, Mary-
land, USA).
RNA interference in ticks
Oligonucleotide primers homologous to I. scapularis and
R. microplus subolesin containing T7 promoters were used
for in vitro transcription and synthesis of subolesin dsRNA
as described previously [10,12], using the Access RT-PCR
system (Promega) and the Megascript RNAi kit (Ambion,
Austin, TX, USA). For the synthesis of R. microplus GI and
GII dsRNAs, oligonucleotide primers GI5: 5'-ATGGAG-
GCCGGGATAGGA and GI3: 5'-TGCTCATTAA-
GACAAATCTC, and GII5: 5'-
GGCCCACGGACAAACCCCTC and GII3: 5'-CGAC-
CGTTTGCCTCATGTC were used, respectively, with the
same procedure described above. The dsRNA was purified
and quantified by spectrophotometry.
Unfed I. scapularis female ticks were injected with approx-
imately 0.5 μl dsRNA in the lower right quadrant of the
ventral surface of the exoskeleton of ticks [10]. Freshly
molted R. microplus females were placed on double-sided
sticky tape with the ventral side upwards and injected with
approximately 0.5 μl dsRNA into the anal aperture using
a syringe mounted on a MM3301-M3 micromanipulator
(World Precision Instruments (WPI), Berlin, Germany)
and connected to an UMPII syringe pump (WPI) [12].
Engorged R. microplus females were injected with 5 μl of
dsRNA (5 × 1010–5 × 1011 molecules/μl) in the right
spiracular plate within 6 hours after dropping off the host
[12]. The injections were done using a 10 μl syringe with
a 1 inch, 33 gauge needle (Hamilton, Bonaduz, Switzer-
land). Control ticks were injected with injection buffer
(10 mM Tris-HCl, pH 7, 1 mM EDTA) alone (saline nega-
tive control). We demonstrated previously that there is no
difference between using an unrelated dsRNA or injection
buffer alone for negative control in tick RNAi experiments
[10].
Two RNAi experiments were conducted with I. scapularis.
In the first experiment, designed to determine the time
after dsRNA injection in which subolesin knockdown
occurs, 20 female ticks per group were injected with sub-
olesin dsRNA or injection buffer. The ticks were held in a
humidity chamber for 1 day after which they were allowed
to feed on a sheep for 10 days. Three ticks from each group
were collected at 1, 3, 6, 9 and 11 days post injection
(dpi). Only the ticks collected after 10 days of feeding (11
dpi) were fed together with male ticks to evaluate the
effect of subolesin knockdown on tick weight. After collec-
tion, ticks were weighed and the tick weight was com-
pared between subolesin dsRNA-injected and saline
controls by Student's t-test (P = 0.05). Internal organs
were then dissected and stored in RNALater (Ambion) for
RNA extraction to determine subolesin mRNA levels by
Prediction of subolesin post-translational modifications Figure 7
Prediction of subolesin post-translational modifications. Sequence alignment of I. scapularis subolesin [Gen-
bank:AAV67031] and human ortholog [Genbank:NP_060534] proteins using the one letter amino acid code. Identical amino 
acids are indicated with asterisks. Three conserved PKC phosphorylation sites were predicted by PIR searching against the 
PROSITE database.BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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real-time RT-PCR. In the second experiment, 100 I. scapu-
laris female ticks per group were injected with subolesin
dsRNA or injection buffer alone. The ticks were held in a
humidity chamber for 1 day and then allowed to feed on
a sheep without males for 5 and 8 days (6 and 9 dpi) in
groups of 50 dsRNA- and 50 saline-injected ticks each.
Ten additional female ticks per group were fed with males
for 10 days to compare the weight of replete dsRNA-
injected and control ticks after RNAi by Student's t-test
with unequal variance (P = 0.05). Unattached ticks were
removed two days after infestation. After feeding, ticks
The regulatory function of subolesin on gene expression may be exerted through interactions with regulatory proteins that act  at the transcriptional and/or translational levels Figure 8
The regulatory function of subolesin on gene expression may be exerted through interactions with regulatory 
proteins that act at the transcriptional and/or translational levels. Tick subolesin interacts with GI and GII proteins 
with putative regulatory functions on gene expression. Other hypothetical interactions with regulatory proteins may exist 
based on data for the human ortholog. The search for human ortholog (C6orf166; [Genbank:NP_060534]) protein-protein 
interactions was done by STRING.
Other hypothetical 
interactions like thus 
identified for the human 
ortholog (C6orf166)
Subolesin
GI
GII (EF-1a)
http://harvester.embl.de/harvester/Q9NW/Q9NW35.htm#STRINGBMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
Page 14 of 16
(page number not for citation purposes)
were removed from the sheep and dissected for RNA
extraction.
For RNAi in R. microplus, unfed and replete female ticks
were injected with GI dsRNA, GII or subolesin dsRNA or
injection buffer alone as described previously [12]. In the
experiment with unfed ticks, 60–76 freshly molted female
ticks were injected and fed on a calf for 15 days with
untreated males to determine female tick mortality,
weight, oviposition and hatching. Tick mortality was eval-
uated as the ratio of dead female ticks 15 dpi to the total
number of female ticks placed on the calf and was com-
pared between dsRNA and mock-injected control ticks by
χ2-test as implemented in Mstat 4.01 (α = 0.01). Ticks
completing feeding and egg masses oviposited by each
tick were weighed individually and the average ± SD were
calculated and compared between dsRNA and saline
injected control ticks by Student's t-test with unequal var-
iance (P = 0.05). In the experiment with replete female
ticks, 6 ticks were used per group. Each tick was weighed
before injection and stored individually in 2 ml Eppen-
dorf tubes with pierced lids in an incubator at 27°C and
95% relative humidity to evaluate oviposition and hatch-
ing after RNAi. The weight of replete ticks before injection
and the eggs mass per tick were compared with the control
saline injected ticks by Student's t-test with unequal vari-
ance (P = 0.05). mRNA levels of RNAi targeted genes were
determined by real-time RT-PCR. For real-time RT-PCR,
internal organs were dissected and total RNA was
extracted from 6 females of each dsRNA- or saline-injected
group after 6 days of feeding and from 100 mg eggs ovi-
posited by injected replete ticks.
Suppression-subtractive hybridization (SSH)
Total RNA was isolated from pooled guts and salivary
glands of I. scapularis female ticks injected with subolesin
dsRNA or injection buffer at 9 dpi (8 days of feeding)
using TriReagent (Sigma) according to manufacturer's
instructions. RNA quality was assessed by gel electro-
phoresis. SSH was performed at Evrogen JCS (Moscow,
Russia) as described previously [6,28]. Tester and driver
RNAs were subtracted in both directions to construct two
SSH libraries enriched for differentially expressed cDNAs
in subolesin dsRNA-injected (reverse-subtracted) and
saline-injected (forward-subtracted) ticks. Approximately
100 clones from each library were randomly picked up
and subjected to differential hybridization with sub-
tracted and non-subtracted probes using the PCR-select
differential screening kit (Clontech, Palo Alto, CA, USA),
which resulted in > 95% candidate differentially expressed
cDNAs.
Microarray construction and analysis
Tick cDNA fragments (384 from each of the reverse and
forward subtracted SSH libraries) were amplified by PCR
using pAL-16 vector-specific primers, purified (Multi-
Screen PCR plates, Millipore, Billerica, MA, USA) and
arrayed onto gamma amino propyl silane coated GAPS II
slides (Corning, Lowell, MA, USA). Eight pools of 12
clones each from an unsubtracted I. scapularis cDNA
library [28] and subolesin cDNA were also arrayed and
used to validate normalization. Total RNA was prepared
from subolesin dsRNA- and saline-injected ticks at 6 and
9 dpi (5 and 8 days of feeding) using the RNeasy Mini Kit
(Qiagen) including the on-column DNA digestion with
the RNase-free DNase set following manufacturer's
instructions. Total RNA (5 μg) were labeled using the
3DNA Array900 kit with Alexa Fluor dyes (Genisphere,
Hatfield, PA, USA), Superscript II (Invitrogen, Carlsbad,
CA, USA), the supplied formamide-based hybridization
buffer and 24 × 60 mm LifterSlips (Erie Scientific, Port-
mouth, NH, USA) according to the manufacturer's (Geni-
sphere) instructions. Hybridization signals were
measured using a ScanArray Express (PerkinElmer, Bos-
ton, MA, USA) and the images were processed using Gene-
Pix Pro version 4.0 (Axon, Union City, CA, USA). Ratios
were calculated as subolesin dsRNA-injected ticks versus
saline-injected control ticks. Normalized ratio values
obtained for each probe were averaged across 50 biologi-
cal replicates and four technical replicates and significant
differences were defined as displaying an expression fold
change greater than 2-fold. All the microarray data were
deposited at the NCBI Gene Expression Omnibus (GEO)
under the platform accession number GPL6394 and the
series number GSE10222.
Real-time RT-PCR analysis
The RNA samples prepared as described above from I.
scapularis female ticks and from R. microplus female ticks
and eggs after RNAi experiments were used for real-time
RT-PCR analysis. The RNA from I. scapularis female ticks
injected with an unrelated 4A8 dsRNA [29] was used as a
control in the analysis of mRNA levels for selected differ-
entially expressed genes after subolesin RNAi. Two prim-
ers were synthesized based on the sequences determined
for subolesin, GI, GII and three differentially expressed
genes after subolesin RNAi (identical to I. scapularis puta-
tive secreted salivary WC peptide [Genbank:AAY66498]
and putative secreted protein [Genbank:AAM93633] and
M. rosenbergii Cu-Zn SOD; [Genbank:AAZ29240]) and
used for real-time RT-PCR analysis of mRNA levels in
dsRNA- and control ticks. Real-time RT-PCR was done
using the QuantiTec SYBR Green RT-PCR kit (Qiagen,
Valencia, CA, USA) and a Bio-Rad iQ5 thermal cycler
(Hercules, CA, USA) following manufacturer's recom-
mendations and oligonucleotide primers and PCR condi-
tions described in Table 4. mRNA levels were normalized
against tick β-actin using the comparative Ct method.
mRNA levels were compared between dsRNA-infected
and control ticks by Student's t-Test (P = 0.05).BMC Genomics 2008, 9:372 http://www.biomedcentral.com/1471-2164/9/372
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Sequence analysis and database search
The sequences of positive clones in the yeast two-hybrid
screen were sequenced and searched for homology with
the PSI-BLAST algorithm through NCBI web site. Proteins
with similar domain architectures were characterized with
CDART [30,31].
The tick cDNAs identified in the microarray analysis as
down or up-regulated by more than two-fold after sub-
olesin RNAi were sequenced and analyzed. Multiple
sequence alignment were performed to exclude vector
sequences and to identify redundant (not unique)
sequences using the program AlignX (Vector NTI Suite V
8.0, InforMax, Invitrogen, Carisbad, CA, USA) with an
engine based on the Clustal W algorithm. Searches for
sequence similarity were performed with the BLASTX pro-
gram against the non-redundant (nr) peptide sequence
database and the database of tick specific sequences at
NCBI and VectorBase. Protein ontology was determined
using the protein reference database [32]. The possibility
of subolesin RNAi off-target effects were analyzed by
searching for exact complementarity between the seed
region (bases 2–8) of all possible 20–22 bp subolesin siR-
NAs and cDNA sequences of tick differentially regulated
genes identified in the microarray analysis, including the
sequence of 3' UTRs when known [23].
The pattern search and predictions for tick GI, GII and
subolesin post-translational modifications were done by
PIR searching against the PROSITE database [33]. The
search for human ortholog (C6orf166; Genbank acces-
sion number NP_060534) protein-protein interactions
was done by STRING [34,35].
Nucleotide sequence accession numbers
The nucleotide sequences of GI, GII and the ESTs reported
in this paper have been deposited in the GenBank data-
base under accession numbers [Genbank:EU436162,
Genbank:EU436163 and Genbank:FD482610–
FD482874], respectively.
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